Eupraxia Pharmaceuticals Inc.
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 2.5M | 3.1M | 3.3M | 3.6M | 2.2M |
| General And Administrative Expense | 2.5M | 3.1M | 3.3M | 3.6M | 2.2M |
| Research And Development | 4.4M | 5.2M | 3.8M | 3.9M | 4.0M |
| Operating Expense | 6.9M | 8.3M | 7.1M | 7.5M | 6.3M |
| Operating Income | -6.9M | -8.3M | -7.1M | -7.5M | -6.3M |
| EBIT | -6.4M | -8.7M | -6.8M | -7.5M | -6.0M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 137.00 | 451.00 |
| Interest Expense Non Operating | 0.00 | 0.00 | 0.00 | 137.00 | 451.00 |
| Interest Income | 180,185 | 255,958 | 309,452 | 218,006 | 304,342 |
| Interest Income Non Operating | 180,185 | 255,958 | 309,452 | 218,006 | 304,342 |
| Net Interest Income | 180,185 | 255,958 | 309,452 | 217,869 | 303,891 |
| Other Income Expense | 332,934 | -733,961 | 50,287 | -266,794 | -21,990 |
| Special Income Charges | 0.00 | 0.00 | -1,075 | -348,339 | 0.00 |
| Gain On Sale Of Security | 332,934 | -733,961 | 51,362 | 81,545 | -21,990 |
| Pretax Income | -6.4M | -8.7M | -6.8M | -7.5M | -6.0M |
| Tax Provision | -623.00 | 5,581 | 2,794 | -- | -- |
| Tax Effect Of Unusual Items | 32.56 | -110,094 | 7,543 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -6.4M | -8.7M | -6.8M | -7.5M | -5.9M |
| Net Income From Continuing Operation Net Minority Interest | -6.4M | -8.7M | -6.8M | -7.5M | -5.9M |
| Net Income Including Noncontrolling Interests | -6.4M | -8.7M | -6.8M | -7.5M | -6.0M |
| Minority Interests | 7,991 | 6,767 | 4,667 | 23,385 | 47,995 |
| Net Income Common Stockholders | -6.4M | -8.7M | -6.8M | -7.5M | -5.9M |
| Net Income | -6.4M | -8.7M | -6.8M | -7.5M | -5.9M |
| EBITDA | -6.3M | -8.7M | -6.7M | -7.5M | -6.0M |
| Normalized EBITDA | -6.6M | -8.0M | -6.8M | -7.2M | -5.9M |
| Reconciled Depreciation | 62,993 | 55,431 | 46,487 | 54,512 | 37,759 |
| Basic EPS | -- | -0.26 | -0.21 | -- | -0.17 |
| Diluted EPS | -- | -0.26 | -0.21 | -- | -0.17 |
| Basic Average Shares | -- | 35.9M | 35.7M | -- | 35.6M |
| Diluted Average Shares | -- | 35.9M | 35.7M | -- | 35.6M |
| Total Unusual Items | 332,934 | -733,961 | 50,287 | -266,794 | -21,990 |
| Total Unusual Items Excluding Goodwill | 332,934 | -733,961 | 50,287 | -266,794 | -21,990 |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.15 | 0.00 | 0.00 |
| Normalized Income | -6.7M | -8.1M | -6.8M | -7.2M | -5.9M |
| Diluted NI Availto Com Stockholders | -6.4M | -8.7M | -6.8M | -7.5M | -5.9M |
| Gain On Sale Of Ppe | 0.00 | 0.00 | -1,075 | 7,243 | 0.00 |
| Insurance And Claims | 247,050 | 232,299 | 261,223 | 276,417 | 291,938 |
| Net Income Continuous Operations | -6.4M | -8.7M | -6.8M | -7.5M | -6.0M |
| Net Non Operating Interest Income Expense | 180,185 | 255,958 | 309,452 | 217,869 | 303,891 |
| Other Gand A | 1.2M | 1.4M | 1.2M | 1.1M | 1.1M |
| Salaries And Wages | 979,476 | 1.5M | 1.8M | 2.3M | 808,132 |
| Total Expenses | 6.9M | 8.3M | 7.1M | 7.5M | 6.3M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 89.0M | 19.8M | 27.5M | 33.1M | 8.7M |
| Cash Cash Equivalents And Short Term Investments | 89.0M | 19.8M | 27.5M | 33.1M | 8.7M |
| Cash Financial | 89.0M | 19.8M | 27.5M | 33.1M | 8.7M |
| Accounts Receivable | -- | -- | -- | -- | -- |
| Receivables | 139,904 | 134,607 | 238,531 | 228,872 | 105,930 |
| Prepaid Assets | 2.3M | 2.9M | 913,283 | 1.1M | 1.1M |
| Current Assets | 91.4M | 22.8M | 28.6M | 34.4M | 9.9M |
| Gross PPE | 1.4M | 1.2M | 1.0M | 884,606 | 909,872 |
| Accumulated Depreciation | -584,869 | -551,833 | -488,556 | -459,690 | -453,379 |
| Net PPE | 851,595 | 688,325 | 546,537 | 424,916 | 456,493 |
| Total Non Current Assets | 949,192 | 766,167 | 626,767 | 505,677 | 474,923 |
| Total Assets | 92.3M | 23.6M | 29.2M | 34.9M | 10.4M |
| Current Debt | -- | -- | -- | -- | -- |
| Current Debt And Capital Lease Obligation | 76,136 | 35,065 | 52,774 | 71,859 | 78,752 |
| Payables | -- | -- | -- | -- | -- |
| Payables And Accrued Expenses | 3.7M | 2.6M | 2.1M | 1.5M | 2.3M |
| Current Accrued Expenses | 3.7M | 2.6M | 2.1M | 1.5M | 2.3M |
| Current Liabilities | 3.8M | 2.6M | 2.2M | 3.1M | 2.4M |
| Long Term Debt And Capital Lease Obligation | 94,467 | -- | -- | -- | 14,297 |
| Long Term Capital Lease Obligation | 94,467 | -- | -- | -- | 14,297 |
| Total Non Current Liabilities Net Minority Interest | 94,467 | 0.00 | 0.00 | 0.00 | 14,297 |
| Total Liabilities Net Minority Interest | 3.9M | 2.6M | 2.2M | 3.1M | 2.4M |
| Common Stock | 191.0M | 117.1M | 116.8M | 116.4M | 116.3M |
| Capital Stock | 222.7M | 148.8M | 148.5M | 148.1M | 116.3M |
| Additional Paid In Capital | 23.5M | 23.0M | 21.9M | 20.5M | 19.5M |
| Retained Earnings | -152.9M | -146.5M | -137.8M | -131.0M | -123.5M |
| Gains Losses Not Affecting Retained Earnings | -3.3M | -2.8M | -4.1M | -4.2M | -2.8M |
| Other Equity Adjustments | -3.3M | -2.8M | -4.1M | -4.2M | -2.8M |
| Common Stock Equity | 58.3M | -9.2M | -3.1M | 1.7M | 9.5M |
| Stockholders Equity | 90.0M | 22.6M | 28.6M | 33.4M | 9.5M |
| Total Equity Gross Minority Interest | 88.4M | 21.0M | 27.0M | 31.8M | 8.0M |
| Minority Interest | -1.6M | -1.6M | -1.6M | -1.6M | -1.5M |
| Total Capitalization | 90.0M | 22.6M | 28.6M | 33.4M | 9.5M |
| Net Tangible Assets | 90.0M | 22.6M | 28.6M | 33.4M | 9.5M |
| Tangible Book Value | 58.3M | -9.2M | -3.1M | 1.7M | 9.5M |
| Working Capital | 87.6M | 20.2M | 26.4M | 31.3M | 7.5M |
| Invested Capital | 58.3M | -9.2M | -3.1M | 1.7M | 9.5M |
| Total Debt | 170,603 | 35,065 | 52,774 | 71,859 | 93,049 |
| Share Issued | 50.6M | 36.0M | 35.8M | 35.6M | 35.6M |
| Ordinary Shares Number | 50.6M | 36.0M | 35.8M | 35.6M | 35.6M |
| Buildings And Improvements | 168,760 | 32,747 | 49,255 | -- | 86,489 |
| Capital Lease Obligations | 170,603 | 35,065 | 52,774 | 71,859 | 93,049 |
| Current Capital Lease Obligation | 76,136 | 35,065 | 52,774 | 71,859 | 78,752 |
| Leases | 125,851 | 124,832 | 118,467 | 118,359 | 126,163 |
| Machinery Furniture Equipment | 230,793 | 211,343 | 144,206 | 139,606 | 163,376 |
| Non Current Prepaid Assets | 97,597 | 77,842 | 80,230 | 80,761 | 18,430 |
| Other Current Borrowings | -- | -- | -- | -- | -- |
| Other Payable | -- | -- | -- | -- | -- |
| Other Properties | 911,060 | 871,236 | 723,165 | 626,641 | 533,844 |
| Pensionand Other Post Retirement Benefit Plans Current | -- | -- | -- | 1.5M | -- |
| Preferred Stock | 31.7M | 31.7M | 31.7M | 31.7M | -- |
| Preferred Stock Equity | 31.7M | 31.7M | 31.7M | 31.7M | -- |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Taxes Receivable | 139,904 | 134,607 | 238,531 | 228,872 | 105,930 |
| Total Tax Payable | -- | -- | -- | 0.00 | 0.00 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -4.5M | -8.3M | -6.0M | -6.0M | -10.2M |
| Cash Flow From Continuing Operating Activities | -4.5M | -8.3M | -6.0M | -6.0M | -10.2M |
| Depreciation And Amortization | 62,993 | 55,431 | 46,487 | 54,512 | 37,759 |
| Depreciation Amortization Depletion | 62,993 | 55,431 | 46,487 | 54,512 | 37,759 |
| Stock Based Compensation | 446,106 | 1.1M | 1.5M | 1.0M | 507,246 |
| Change In Working Capital | 1.7M | -1.5M | -707,399 | 568,715 | -4.7M |
| Change In Receivables | -7,278 | 112,771 | -8,675 | -182,693 | 50,432 |
| Change In Payables And Accrued Expense | 1.2M | 340,201 | -894,360 | 870,816 | -4.7M |
| Change In Payable | -- | -- | -- | 870,816 | -- |
| Other Non Cash Items | -18,922 | -20,250 | -19,184 | -15,846 | -14,228 |
| Capital Expenditure | -60,377 | -166,225 | -169,044 | -44,315 | -42,275 |
| Purchase Of PPE | -60,377 | -166,225 | -169,044 | -44,315 | -42,275 |
| Net PPE Purchase And Sale | -60,377 | -166,225 | -169,044 | -43,757 | -42,275 |
| Investing Cash Flow | -60,377 | -166,225 | -169,044 | -43,757 | -42,275 |
| Cash Flow From Continuing Investing Activities | -60,377 | -166,225 | -169,044 | -43,757 | -42,275 |
| Repayment Of Debt | 0.00 | 0.00 | 0.00 | 0.00 | -4.6M |
| Net Issuance Payments Of Debt | 0.00 | 0.00 | 0.00 | 0.00 | -4.6M |
| Issuance Of Capital Stock | 73.9M | 0.00 | 0.00 | 31.7M | 0.00 |
| Net Common Stock Issuance | 73.9M | 0.00 | 0.00 | 31.7M | 0.00 |
| Financing Cash Flow | 73.9M | 239,778 | 429,923 | 31.7M | -4.6M |
| Cash Flow From Continuing Financing Activities | 73.9M | 239,778 | 429,923 | 31.7M | -4.6M |
| Effect Of Exchange Rate Changes | -137,324 | 552,747 | 95,496 | -1.3M | 178,855 |
| Changes In Cash | 69.3M | -8.2M | -5.7M | 25.7M | -14.8M |
| Beginning Cash Position | 19.8M | 27.5M | 33.1M | 8.7M | 23.3M |
| End Cash Position | 89.0M | 19.8M | 27.5M | 33.1M | 8.7M |
| Free Cash Flow | -4.6M | -8.5M | -6.2M | -6.0M | -10.2M |
| Interest Paid Supplemental Data | -- | -- | -- | 102.00 | -- |
| Change In Account Payable | -- | -- | -- | 870,816 | -- |
| Change In Prepaid Assets | 556,374 | -1.9M | 195,636 | -119,408 | -69,461 |
| Common Stock Issuance | 73.9M | 0.00 | 0.00 | 31.7M | 0.00 |
| Depreciation | 62,993 | 55,431 | 46,487 | 54,512 | 37,759 |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 1,075 | -7,243 | 0.00 |
| Long Term Debt Payments | -- | -- | -- | 0.00 | -- |
| Net Foreign Currency Exchange Gain Loss | -328,491 | 755,825 | -50,182 | -68,294 | 9,951 |
| Net Income From Continuing Operations | -6.4M | -8.7M | -6.8M | -7.5M | -6.0M |
| Net Long Term Debt Issuance | -- | -- | -- | 0.00 | -- |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | -4.5M |
| Operating Gains Losses | -328,491 | 755,825 | -49,107 | -75,537 | 9,951 |
| Proceeds From Stock Option Exercised | 6,785 | 239,778 | 429,923 | 25,863 | 0.00 |
| Sale Of PPE | 0.00 | -- | -- | 558.00 | 0.00 |
| Short Term Debt Payments | 0.00 | 0.00 | 0.00 | 0.00 | -4.5M |
| Unrealized Gain Loss On Investment Securities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |